Biologics News

This randomized study with a minimum 2-year follow-up showed patients who received platelet-rich plasma injection at the end of arthroscopic hip surgery for femoroacetabular impingement had less pain at 48 hours postoperatively and fewer joint effusions at 6 months compared with those who did not receive augmented treatment.

Interventional Spine Inc. recently announced FDA clearance of its next generation Opticage expandable interbody fusion device.

PHILADELPHIA — Compared to autograft bone, which is considered the gold standard graft material for spine fusion, demineralized bone matrix in the form of a sponge was associated with comparable fusion rates and less pain when used for posterolateral lumbar fusion, according to a presenter at the Philadelphia Spine Research Symposium, here.

DALLAS — Data presented here at the American Association of Hip and Knee Surgeons Annual Meeting indicated both hemoglobin reduction and total blood loss were comparable between patients who were administered tranexamic acid either orally or intravenously during primary total knee arthroplasty.

Cerapedics recently announced the FDA has approved the company’s premarket approval application for the i-FACTOR Peptide Enhanced Bone Graft.

Regenexx recently announced its receipt of a U.S. patent for a same-day stem cell procedure used in the treatment of spine pain, joint injuries and degenerative orthopedic conditions.

A cross-sectional study of orthopedic patients treated in Seongnam-si, Korea, showed 91.2% of patients exhibited either insufficient or deficient levels of vitamin D.

Bioventus recently announced the launch of SUPARTZ FX, which now has an expanded safety label to permit for repeat injection cycles to help patients with knee osteoarthritis manage pain and remain active.

Joimax recently launched its two newest products, the EndoLIF On-Cage and iLESSYS Delta interlaminar system, at the 30th annual North American Spine Society meeting in Chicago.

Solvay Specialty Polymers recently announced its Zeniva polymer has been chosen by Vertera Spine to develop its PEEK Scoria, a porous surface technology for intervertebral joint fusion.